https://cancerous.eu/egfr-mutant-non-small-cell-lung-carcinoma-molecular-pathology-tyrosine-kinase-resistance-osimertinib/2026-10-20T12:22:12+00:00https://cancerous.eu/glioblastoma-multiforme-gbm-mgmt-methylation-idh1-mutation-temozolomide-radiotherapy/2026-10-20T12:15:55+00:00https://cancerous.eu/pancreatic-ductal-adenocarcinoma-pdac-kras-g12d-drivers-stroma-desmoplasia-folfirinox/2026-10-20T12:43:41+00:00https://cancerous.eu/triple-negative-breast-carcinoma-tnbc-brca1-deficiency-parp-inhibitors-pembrolizumab/2026-10-20T13:11:25+00:00https://cancerous.eu/car-t-cell-therapy-chimeric-antigen-receptor-cd19-targeting-cytokine-release-syndrome-axicabtagene/2026-10-20T13:43:13+00:00https://cancerous.eu/colorectal-carcinoma-microsatellite-instability-msi-high-mismatch-repair-deficiency-nivolumab/2026-10-20T14:43:29+00:00https://cancerous.eu/chronic-myelogenous-leukemia-cml-philadelphia-chromosome-bcr-abl-fusion-imatinib-mechanics/2026-10-20T15:43:53+00:00https://cancerous.eu/cutaneous-melanoma-braf-v600e-mutation-mek-inhibitors-dual-checkpoint-blockade/2026-10-20T16:43:15+00:00https://cancerous.eu/prostate-adenocarcinoma-androgen-receptor-signaling-castration-resistance-enzalutamide/2026-10-20T18:44:59+00:00https://cancerous.eu/clear-cell-renal-cell-carcinoma-ccrcc-vhl-gene-inactivation-hif-2a-pathways-belzutifan/2026-10-20T19:48:51+00:00https://cancerous.eu/evolution-of-car-t-therapy-functional-engineering-manufacturing-innovation-and-future-in-vivo-strategies/2026-10-20T20:44:24+00:00https://cancerous.eu/new-perspective-on-epigenetic-modification-and-immunotherapy-in-endemic-and-advanced-endometrial-cancer-molecular-pathology-and-clinical-trials/2026-10-20T21:43:01+00:00https://cancerous.eu/clinical-efficacy-and-safety-of-immunotherapy-after-concurrent-chemoradiotherapy-in-advanced-esophageal-cancer/2026-10-20T22:43:29+00:00https://cancerous.eu/nucleotide-excision-repair-in-tumor-response-to-dna-damaging-anticancer-therapies-molecular-pathology-pharmacological-mechanisms-and-clinical-resistance/2026-10-20T23:45:10+00:00https://cancerous.eu/oncogenic-mutations-in-non-small-cell-lung-cancer-from-molecular-mechanisms-to-clinical-practice/2026-10-21T00:43:31+00:00https://cancerous.eu/nivolumab-in-patients-with-advanced-solid-tumors-with-ctdna-defined-high-blood-tumor-mutational-burden-a-phase-ii-trial/2026-10-21T01:43:10+00:00https://cancerous.eu/pembrolizumab-combined-with-disitamab-vedotin-in-human-epidermal-growth-factor-receptor-2-positive-metastatic-colorectal-cancer/2026-10-21T02:43:07+00:00https://cancerous.eu/epitope-generation-gateway-a-biological-context-dependent-approach-to-cancer-vaccine-development/2026-10-21T03:43:08+00:00